TGVP
1825 South Grant Street, Suite 200, San Mateo, CA, 94402, United States
Overview
TGVP is a US corporate venture capital division of TOPPAN, Inc. The San Mateo-based company was founded in 2022 and specializes in venture capital investments in US startups in digital transformation and sustainability.
- Total investments
- 5
- Lead investments
- 0
- Investments · 12mo
- 4
- Active investors
- 3
Sector focus
- Venture Capital
Investment portfolio
- Databento
Participated · Series B · Jul 2026
Databento provides a unified API delivering real-time and historical market data across futures, options, and equities, owning the market data stack end-to-end and colocating servers at exchanges to capture data directly. The company emphasizes performance, reliability, and a developer-friendly experience, and reports more than doubled active API users in recent months. Financially, Databento reached profitability with 24 employees, grew revenue 6.65x year over year, and has maintained over 97% enterprise logo retention since inception. It plans to expand its infrastructure footprint to more than 20 data centers worldwide and has secured over 100 petabytes of additional storage capacity. Databento aims to broaden coverage across asset classes and geographies as part of its growth strategy.
- LighthouseAI
Participated · Series A · Apr 2026
LighthouseAI provides a centralized platform that combines software and a team of state licensing experts to manage pharmaceutical licensing and compliance across every U.S. state and jurisdiction. Its customers include manufacturers, wholesale distributors, third-party logistics providers, 503A and 503B facilities, pharmacies, repackagers, reverse distributors, virtual manufacturers, and healthcare providers. The company launched Rapid Assessments, a product that analyzes more than 100 facility attributes and produces a guaranteed set of regulatory requirements across 55 U.S. jurisdictions instantly. LighthouseAI serves 250 customers and processed 2025 change-of-ownership transactions representing more than $12 billion in combined revenue. The company reached initial profitability in Q4 2025, employs 85 people, and has recently expanded its commercial leadership with the appointment of a Chief Commercial Officer. Series A proceeds are intended to fund delivery improvements, further product development, and expanded services to support growth.
- Fabric8Labs
Participated · Equity · Nov 2025
Fabric8Labs, founded in 2015 and headquartered in San Diego, has created a patented Electrochemical Additive Manufacturing (ECAM) platform that builds metal parts atom-by-atom at room temperature, eliminating costly post-processing while achieving exceptional feature resolution and surface finish. The technology enables production of next-generation components such as direct-to-chip cooling structures, 3D antennas printed on PCBs, and high-current interconnects for electric vehicles. With ECAM, customers can move seamlessly from prototyping to high-volume output on a single manufacturing line. Backed by an ISO9001-certified, ITAR-registered U.S. facility, Fabric8Labs plans to expand production capacity from 5 million to 22 million components annually. The company is hiring across manufacturing, design, quality, and process engineering to meet demand from AI/HPC, wireless communications, and power electronics sectors. Its U.S. manufacturing presence also addresses supply-chain resiliency requirements for advanced electronics customers.
- Medmo
Participated · Series A · Oct 2025
Medmo operates an end-to-end orchestration platform that allows ordering providers to manage referrals for diagnostic imaging exams such as MRIs, CTs, mammograms, ultrasounds, and X-rays. The New York-based company’s technology automates the entire patient journey—from initial engagement and scheduling through prior authorization and delivery of results—helping provider groups streamline radiology workflows. Medmo’s solution is live in all 50 states and has facilitated more than one million patient journeys to date. Its AI-powered care-coordination capabilities have made it a preferred platform for providers seeking to improve efficiency and patient experience. With its expanding footprint, the company plans to build additional offerings tailored for insurance carriers. The recently secured capital will fund these developmental efforts while supporting broader operational growth.
- Verdagy
Participated · Series B · Aug 2023
Verdagy develops Advanced Alkaline Water Electrolysis (AWE) eDynamic® electrolyzers designed for large-scale green hydrogen production. Its technology targets low levelized cost of hydrogen (LCOH) through high current densities, the widest dynamic range in the industry, and fast response to match renewable power. The company announced a gigawatt-scale Silicon Valley factory in 2023 and operates R&D and highly automated commercial pilot plants in Moss Landing, California. Verdagy plans to commence shipments from its Newark, CA manufacturing facility in 2025 to enable infrastructure-scale deployments. To accelerate high-volume manufacturing, Verdagy has been awarded a $39.6 million grant from the U.S. Department of Energy (pending negotiations). The company is ramping up commercial deployments and is committed to helping meet the DOE's $2/kg LCOH target by 2026. Verdagy develops scaling electrolyzer technologies for industrial markets, headquartered in Moss Landing, CA. Its core product is the eDynamic® family; the company is accelerating launch and commercialization of the eDynamic 20 megawatt (MW) electrolyzer module. The 20MW module is intended to serve as a fundamental unit for future systems at the 200MW scale and beyond. Verdagy will expand deployments after initial commercial unit deployments with existing partners to customers in heavy industries such as oil and gas, ammonia, steel and e‑fuels to support industrial decarbonization. The company’s leadership includes CEO Marty Neese (SunPower, Ballard), COO Peter Cousins (scaled Tesla gigafactories) and founder Dr. Ryan Gilliam (founder of Fortera and Chemetry). Verdagy has created a membrane-based electrolysis technology that blends advantages of alkaline water electrolysis (AWE) and proton-exchange membrane (PEM) approaches, using very large active-area cells that can operate at high current densities and wide dynamic ranges. The company’s single-element architecture focuses on proprietary interior cell design—heat dissipation, gas/liquid circulation and flow management—which Verdagy says is difficult to replicate. Its cells enable both efficient operation in a max-efficiency range and the ability to absorb excess renewable electricity to produce large amounts of hydrogen for storage or use. Verdagy is targeting industrial hydrogen applications—on-site or near-site supply for oil refining, fertilizer production, food processing and metal-alloy production—where it says a smaller footprint and lower lifecycle emissions are beneficial. The technology is patent-pending and the company emphasizes industrial-scale deployment tied to renewable power sources like wind and solar. Financially, Verdagy completed an over-subscribed $25 million strategic investor round to support its development and commercialization efforts.